NEW YORK (GenomeWeb News) – Prodesse has licensed Invitrogen’s LUX PCR reagents for use in molecular diagnostics, the companies said on Friday.
 
The agreement marks the first use of the LUX (Light Upon eXtension) PCR chemistries in diagnostic assays, the companies said.
 
Invitrogen said that the LUX reagents can be used in gene expression studies, biomarker analysis, and functional genomics experiments and enable users to examine multiple targets in one experiment.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.